← Leaderboard

Infectious

Measles

A highly contagious viral infection caused by the measles virus. Symptoms appear 8-12 days after exposure and include a rash, cough, fever and muscle pains that can last 4-7 days. Measles vaccines are available to provide prophylaxis, usually combined with mumps and rubella vaccines (MMR).

Balanced: 35th of 142Biggest burden: 45th of 142Most neglected: 9th of 142

Starter kit · coming soon

Start building on measles

See a finished example: the malaria starter kit →

Where the field stands

  1. 01

    Early understanding

    No strong gene target or drug candidate yet

  2. 02

    Target found

    At least one gene target with strong evidence

  3. 03

    Drug candidates

    Preclinical or phase 1 drug candidates

  4. 04

    In trials

    Drug candidates in phase 2 or later

  5. 05

    Has approved drugs

    At least one approved drug; not necessarily a cure

Derived from Open Targets drug and target data, not self-reported.

Healthy years lost (DALYs), 2023

12.5M

95% range 5.1M to 22.2M

Deaths, 2023

144k

People living with it, 2023

519k

GBD cause: Measles (exact match)

Research attention

Active clinical trials

20

All clinical trials, ever

202

Papers published, 2025

303

Active trials per million healthy years lost

1.6

Lower means fewer trials for the size of the problem

What there is to build on

Open Targets Platform ↗

Gene targets with strong evidence

0

of 532 associated genes

Top associated genes

TMC3CD40LGC4BCD46KIR3DL1

Drugs and clinical candidates

8

Approved drugs

1

Identifiers

Open Targets
MONDO_0004619
ICD-10
B05

Trial and paper counts are rough measures of attention, not of progress. This page is for research planning, not medical advice.